Le Lézard
Classified in: Health, Business
Subjects: TNM, NPT

The National Osteoporosis Foundation Announces Formation of the Paget Disease Initiative

WASHINGTON, Oct. 6, 2017 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF), the nation's leading healthcare organization dedicated to bone health, announced today that the Paget Foundation has merged with NOF. NOF has established the Paget Disease Initiative, which will be the premier resource for information on Paget's disease of the bone, the second most prevalent bone disease following osteoporosis.

National Osteoporosis Foundation. (PRNewsFoto/National Osteoporosis Foundation)

Paget's disease is a chronic disorder that typically results in enlarged and deformed bones in one or more regions of the skeleton. Excessive bone breakdown and formation can cause the bones to weaken, leading to bone pain, arthritis, noticeable deformities and fractures. Similar to osteoporosis, many patients may not realize they have Paget's disease until serious complications have developed.

"Merging the Paget Foundation with NOF brings together two leading national nonprofit organizations with complementary missions," said Amy Porter, Executive Director and CEO, National Osteoporosis Foundation. "As a unified organization, we'll work to bring attention to the importance of good bone health at every age with the goal of sparing millions of Americans from the pain and suffering associated with bone disease."

As part of the merger, NOF will offer online resources on Paget's disease and other bone-related conditions and an up-to-date directory of Paget's disease specialists. In addition, two members of the Paget Foundation board have joined NOF's Board of Trustees. The NOF Board has created a Paget's disease committee to keep abreast on the latest issues and developments with the disease.

NOF recently elected the following members of the Paget Foundation board to its Board of Trustees: Kenneth Ward Lyles, MD, Professor of Medicine and Senior Fellow in the Center for the Study of Aging and Human Development at Duke University and VA Medical Center and a Geriatric Medicine and Metabolic Bone Diseases Specialist for Duke Health and Frederick R. Singer, MD, Director of the Endocrine/Bone Disease Program at the John Wayne Cancer Institute at Providence Saint John's Health Center and a Clinical Professor of Medicine at the David Geffen School of Medicine at the University of California at Los Angeles.

"Merging with NOF is an exciting opportunity to reduce the impact of bone disease," said Dr. Frederick R. Singer, past Chairman of the Board of Directors of the Paget Foundation and past president of the American Society for Bone and Mineral Research. "We are confident the merged organization can bring additional attention to the importance of diagnosis and treatment to lessen the painful symptoms of osteoporosis and Paget's disease, ultimately preventing fractures before they occur."

About the National Osteoporosis Foundation 

Established in 1984, the National Osteoporosis Foundation is the nation's leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.

About the Paget Foundation 

The Paget Foundation, a national voluntary health agency founded in 1978, is the premier resource for information on Paget's disease of bone. Paget's disease is the second most prevalent bone disease after osteoporosis.

Contact: Claire Gill 
(703) 647-3025

SOURCE National Osteoporosis Foundation

These press releases may also interest you

15 déc 2017
The massive Thomas Fire, now the 4th largest in California history, continues to burn in both Santa Barbara and Ventura counties.  To date, the fire has destroyed a total of 921 structures, damaged 200 and is threatening 18,000 more. Over 95,000...

15 déc 2017
ESSA Pharma Inc. ("ESSA" or the "Company") announces an update to its previously announced pricing press release. The Company intends to issue up to 75,000,000 units of the Company ("Units") at a price of US$0.20 per Unit (the "Offering Price") for...

15 déc 2017
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into RE/MAX Holdings, Inc. .   On November...

15 déc 2017
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Triangle Capital Corporation , if they purchased the...

15 déc 2017
Serving in any branch of the military can be a deeply enriching experience. But while service members are lauded for their sacrifices, they often need to finance their educations by taking out student loans. In return for their service, there are...

15 déc 2017
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synergy Pharmaceuticals, Inc. ("Synergy" or the "Company") . If you invested in Synergy stock or options between...

News published on 6 october 2017 at 09:08 and distributed by: